JAMA Otolaryngology-- Head & Neck Surgery
5-ARI use is tied to lower laryngeal cancer risk in men
In a Swedish cohort, 5-ARI users had a 17% lower risk of laryngeal or hypopharyngeal squamous cell carcinoma than nonusers (adjusted hazard ratio, 0.83).In a Swedish cohort, 5-ARI users had a 17% lower risk of laryngeal or hypopharyngeal squamous cell carcinoma than nonusers (adjusted hazard ratio, 0.83).
Cohort study in peoplePopulations